r software rstudio version 2023.06.0 build 421 (RStudio)
90
Structured Review
RStudio
r software rstudio version 2023.06.0 build 421
R Software Rstudio Version 2023.06.0 Build 421, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+software+rstudio+version+2023%2E06%2E0+build+421/rstudio+version+1+3+1093/pm39128588-73-10-12
Average 90 stars, based on 1 article reviews
R Software Rstudio Version 2023.06.0 Build 421, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+software+rstudio+version+2023%2E06%2E0+build+421/rstudio+version+1+3+1093/pm39128588-73-10-12
Average 90 stars, based on 1 article reviews
r software rstudio version 2023.06.0 build 421 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Reduced FNDC5-AMPK signaling in diabetic atrium increases the susceptibility of atrial fibrillation by impairing mitochondrial dynamics and activating NLRP3 inflammasome. Article Snippet: Fibronectin type III domain-containing protein 5 (FNDC5) exerts potential anti-arrhythmic effects.. However, the function and mechanism of FNDC5 in diabetes-associated atrial fibrillation (AF) remain unknown.. In this study, bioinformatics analysis, in vivo and in vitro experiments were conducted to explore the alteration and role of FNDC5 in diabetes-related atrial remodeling and AF susceptibility. |